TOKYO - Japan has given up on its target of approving Fujifilm Holdings Corp.'s anti-influenza drug Avigan this month as a treatment for coronavirus patients after an interim clinical test report showed no clear efficacy, health minister Katsunobu Kato said Tuesday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
